Tyler R. Trippetti, MPH

Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania

JCP
Prevalence of GLP-1 Receptor Agonist Use Among Privately Insured Individuals with Mood Disorders
Brief Report

June 1, 2026

High fill rates of GLP-1 receptor agonist prescriptions in those with mood disorders could indicate that multimorbidity begets more treatment.
, , , et al

Insightful. Evidence-based. Human-centered.

Listen to the JCP Podcast Now
Figure: Digital illustration shows a human head with neural connections and podcast title over a dark blue patterned background.

Subscribe to read
more articles

Subscribe